1 ML ixekizumab 80 MG/ML Prefilled Syringe

Known as: IXEKIZUMAB 80MG/ML INJ,SYR,1ML [VA Product], ixekizumab 80 MG per 1 ML Prefilled Syringe, IXEKIZUMAB 80MG/ML INJ 1ML SYR 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2017-2017
02420172017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND Scalp is a frequently affected and difficult-to-treat area in psoriasis patients. OBJECTIVE We assessed the efficacy… (More)
Is this relevant?
2017
2017
BACKGROUND AND OBJECTIVES Ixekizumab demonstrated greater efficacy than placebo and etanercept in UNCOVER-3. Subgroup analysis of… (More)
Is this relevant?
2017
2017
BACKGROUND: Newer psoriasis treatments can achieve greater levels of efficacy than older systemic therapies; however, current… (More)
Is this relevant?
2017
2017
BACKGROUND Patients with psoriasis who have an inadequate response to one biologic may benefit from switching to a new biologic… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?